Thomas Bumol

Thomas Bumol

Director/Board Member chez OMEROS CORPORATION

Fortune : 34 500 $ au 31/03/2024

70 ans
Health Technology
Commercial Services
Consumer Services

Profil

Thomas F.
Bumol
is currently an Independent Director at Omeros Corp., a Director at Revalesio Corp., an Executive Director & Executive Vice President at Allen Institute For Immunology, a Director at Spine BioPharma, Inc., and an Independent Director at Tentarix Biotherapeutics LP.
Previously, he worked as a Director at PanTheryx, Inc., Senior VP-Biotechnology & Autoimmunity Research at Eli Lilly & Co., President at Applied Molecular Evolution, Inc., and Vice President-Research Technologies & Proteins at Lilly Research Laboratories.
He obtained his undergraduate degree from the University of Michigan in 1975 and his doctorate degree from the University of Minnesota in 1980.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
12/09/2023 10 000 ( 0,02% ) 34 500 $ 31/03/2024

Postes actifs de Thomas Bumol

SociétésPosteDébut
OMEROS CORPORATION Director/Board Member 09/02/2019
Director/Board Member 01/01/2018
Director/Board Member 01/10/2020
Director/Board Member 20/05/2022
Director/Board Member -
Tous les postes actifs de Thomas Bumol

Anciens postes connus de Thomas Bumol

SociétésPosteFin
ELI LILLY AND COMPANY Chief Tech/Sci/R&D Officer 01/12/2017
Director/Board Member -
Chief Tech/Sci/R&D Officer -
President -
Voir l'expérience en détail de Thomas Bumol

Formation de Thomas Bumol

University of Michigan Undergraduate Degree
University of Minnesota Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Thomas Bumol

Relations

100 +

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
ELI LILLY AND COMPANY

Health Technology

OMEROS CORPORATION

Health Technology

Entreprise privées7

Health Services

Health Technology

Commercial Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Thomas Bumol